RxDoctor Payments Data

Yazan Duwayri, MD

Vascular Surgery · Atlanta, GANPI 1487819132

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (29.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Cook Incorporated at 38.5% of the total. Among vascular surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$44,312in general payments, 2019–2025

Across 129 payments — averaging $343.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$17K
  • Boston Scientific$8K
  • W. L. Gore & Associates, Inc.$8K
  • Cook Medical LLC$8K
  • Cook Research Incorporated$1K
  • Medtronic$898
  • plus $2K from 6 others
$239,896in research payments, 2019–2025

Across 104 payments — averaging $2306.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cook Research Incorporated$134K
  • Shape Memory Medical Inc.$44K
  • Bolton Medical Inc$39K
  • W. L. Gore & Associates, Inc.$23K

What the payments were for

  • Consulting fees$13,16030%
  • Speaking & faculty fees$12,24028%
  • Grants$620%
  • Travel & lodging$10,97925%
  • Food & beverage$7,87118%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,312 in reported general payments places this provider in the 90th percentile of 176 vascular surgery providers in Georgia.

See all vascular surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$124,149
Medicare patients
440
Services billed
697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban52$14,633
BrilintaTicagrelor15$6,360
ClopidogrelClopidogrel Bisulfate85$700
Cilostazol13$419
Atorvastatin Calcium42$391
Methylprednisolone15$69

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →